BlackRock Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $736K | Hold |
71,478
| – | – | ﹤0.01% | 2860 |
|
|
2016
Q3 | $723K | Buy |
71,478
+6,946
| +11% | +$70.3K | ﹤0.01% | 2841 |
|
|
2016
Q2 | $725K | Buy |
64,532
+8,601
| +15% | +$96.6K | ﹤0.01% | 2834 |
|
|
2016
Q1 | $764K | Buy |
55,931
+1,109
| +2% | +$15.1K | ﹤0.01% | 2660 |
|
|
2015
Q4 | $1.04M | Buy |
54,822
+443
| +0.8% | +$8.4K | ﹤0.01% | 2570 |
|
|
2015
Q3 | $1.02M | Buy |
54,379
+41
| +0.1% | +$770 | ﹤0.01% | 2582 |
|
|
2015
Q2 | $809K | Buy |
54,338
+52,996
| +3,949% | +$789K | ﹤0.01% | 2915 |
|
|
2015
Q1 | $20K | Buy |
1,342
+236
| +21% | +$3.52K | ﹤0.01% | 3431 |
|
|
2014
Q4 | $15K | Hold |
1,106
| – | – | ﹤0.01% | 3528 |
|
|
2014
Q3 | $14K | Buy |
1,106
+40
| +4% | +$506 | ﹤0.01% | 3528 |
|
|
2014
Q2 | $11K | Sell |
1,066
-15,986
| -94% | -$165K | ﹤0.01% | 3596 |
|
|
2014
Q1 | $229K | Buy |
+17,052
| New | +$229K | ﹤0.01% | 3197 |
|